GPRC5D
Plasma cell antigen targeted by talquetamab (bispecific) in relapsed/refractory multiple myeloma; emerging GPRC5D CAR-T trials.
No Drugs found for this biomarker.
Plasma cell antigen targeted by talquetamab (bispecific) in relapsed/refractory multiple myeloma; emerging GPRC5D CAR-T trials.
No Drugs found for this biomarker.